Propanc Biopharma Inc (PK) (PPCB) Quote

My take is they have no special sauce…only dilution.

More dilution, nice the executives enjoy "fat cat" salaries and trips to expensive trade shows wining and dinning on shareholders monies. Maybe they should cut their salaries to zero until they produce something of value for their shareholders, doubtful b/c they'll just milk this for as long as people buy into their narrative that the company has a "special sauce" worth billions.

~ 47 million shares added to the Outstanding Share Count since 3-9-2024:
Outstanding Shares 119,335,129 04/09/2024
Restricted Shares 727,859 04/09/2024
Unrestricted Shares 118,607,270 04/09/2024 https://www.otcmarkets.com/stock/PPCB/security

No kidding. Everyone sold bc they gave out no new information.

More like a ball buster

lol

News: Propanc Biopharma’s CEO Shares Views on Revolutionizing Cancer Treatment: An Inside Look at Drug Development & Strategic Financing

Show with Joel Block, “Your Advantage Play®, In Search of the Ultimate Competitive Advantage”

MELBOURNE, Australia--(BUSINESS WIRE)-- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s CEO, Mr. James Nathanielsz, shares his views on revolutionizing cancer treatment with an inside look at drug development and strategic financing. Mr. Nathanielsz appeared on a show with Mr. Joel Block, a weekly podcast on killer business strategies and how the best leaders make them work. In this week’s episode, Mr. Nathanielsz discusses the competitive advantage of the Company and its enzyme treatment for metastatic cancer. Some key points to the competitive advantage highlighted by Mr. Nathanielsz include:

Global Financing Strategy: Mr. Nathanielsz emphasizes the company's global view on accessing funds and its current pursuit of series A financing, showcasing a strategic approach to securing financial support.
Role of Being Public: Going public in the U.S. enabled the company to raise significant capital, highlighting the advantages of being a small public company in accessing funding and fostering advancements in drug development.
Ethical Communication and Due Diligence: Mr. Nathanielsz underscores the importance of ethical communication and thorough due diligence to build credibility, emphasizing the company's commitment to honesty and integrity in drug development.
Drug Development Milestones and Patient Access: The company's main objective is to make their drug accessible to as many patients as possible, prioritizing patient impact over company success, reflecting a patient-centric approach to healthcare.
Science-Based Differentiation and Market Opportunity: The guest emphasizes prior human experience with the drug, safety, and efficacy, and its differentiation in the oncology market, identifying a strong scientific foundation for competitive advantage.
The show, entitled, “Your Advantage Play®, In Search of the Ultimate Competitive Advantage,” has been on the air for 5 years with over 185 episodes released. It has been rated in the top 5% of all podcasts worldwide and featured CEOs of several public companies as well as some of the most highly regarded advisory talent in the country. It targets senior executives of middle market companies (generally $20 million to $1 billion in annual revenues) – but also includes a wider audience of C-Suite executives from all segments of corporate America.

Mr. Block is a blackjack player turned venture capitalist and hedge fund manager who has participated in $1 billion dollars' worth of deals. Joel Block has adapted these skills, attitudes, and philosophies to business. His keynote speeches and media appearances expose Advantage Play® (AP), the art of knowing what comes next because, for APs, winning is inevitable.

To access the in-depth discussion with Mr. Nathanielsz on Spotify, click here: https://open.spotify.com/episode/0MVXBuujK6iGfvAzhuVZ9j?si=Ib-ST12ORcGQiEF_QTrvZw

About Your Advantage Play®, In Search of the Ultimate Competitive Advantage:

Joel Block’s weekly show on killer business strategies and how the best leaders make them work, located on https://redcircle.com/shows/your-advantage-play https://www.otcmarkets.com/stock/PPCB/news/story?e&id=2819222

Ouch PPCB!

I will hold until Friday. Lack of info is not interesting. Pump and dump!😒

The call was so amateurish. On top of the pisspoor audio quality, they could not even agree on the way forward. The German doc seemed to be on another wavelength than the others. Anyway, any result is still two years away at minimum, once toxicity tests, dosage issues are completed. CEO will pocket another million or so in the process. Strange that the Spanish professor from Jaen all but disappered from the radar screens. She seemed the only one to understand what is going on (but that's perhaps why she jumped ship or was disposed of).
Anyway, zero hard data was provided as to PRP efficacy (no side effect but no life was saved either, just a way to prolong your miserable end of life and enjoy your cancer a bit longer)

Check this out..
This video was posted 3 weeks ago..
I saw it the day it came out... CEO talks about series A Financing...



Then you goto Allele Capitals Website:

Read the reviews.. one private company successfully got the series a done..

interesting..

the call is being hosted by Allele Capital and they have Nasdaq Companies and Private Companies on their "engagements" page. Allele Capital has raised money for a few of them. https://www.allelecapital.com/engagements

PPCB is the only OTC stock they have worked with (that I can see)!

“This is going to be a blockbuster”-
CSO Kenyon

nice!!! thanks!!!!!!

“No side effects.” -CSO Kenyon

Ceo is on right now.

5 panelist.

I freaking tried. The stupid ass “linked in” video doesn’t have any sound.

I’m so fking pissed.

Wait.. I think it’s finally working.

It’s on right now I’m watching.

Idk if this is live or a replay ?

did you listen to the call today? PPS is down and im wondering if any news from the call is the reason why.

$PPCB, It has potential to explode. imo.

This could hit pennyland big time if they let it run! I’d love to see it.

Float is only approximately 80 million from my estimation count of watching everyday since the latest ss update.

We’ll see…

Bottom line…
I think it’s worth a lot more than the current market cap. (2-300k?) that’s peanuts for a cancer stock with this type of TAM and potential market share.

I already did my research on this ticker. I know PRP has blockbuster potential.

Imo., PPCB could potentially have a good run this year.

Ooooof big shot of cannolis

Oh boy fluffy of buys maybe big news pre market

im watching.... I'm all-in on a different ticker so PPCB has been and is usually just a short hold for me.

Good Job!

.004

I got .003 bidding low .003s

and I got out yesterday!!!! This is my luck with PPCB, I can never seem to catch a run!

Good Luck To You!

Big news coming

I’m in $PPCB share structure + chart + catalyst… added .003 pic.twitter.com/jxXeSlwDFF— TweetVestor3 (@TVestor3) March 27, 2024

is anyone gonna listen/watch the conference call that is gonna happen on Thursday? Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study

Management will provide insights on the remarkable results from the compassionate use study, the steps being undertaken to advance the Company’s lead asset, PRP, to a Phase 1b, First-in-Human (FIH), clinical study, and its future development pathway

The call will be held on March 28, 2024, at 2:00pm, EST https://www.otcmarkets.com/stock/PPCB/news/story?e&id=2774171

Im ready with my shares!

Share Structure Updated, close to 20 million shares added;

Outstanding Shares: 72,101,012 03/09/2024
Restricted Shares: 727,859 03/09/2024
Unrestricted Shares: 71,373,153 03/09/2024

https://www.otcmarkets.com/stock/PPCB/security

No chance it holds…they are on the dilution juice. Your cash is their juice

Don’t encourage this fraud like co

Please don’t buy this fake public co
The ceo owns the only voting stock..
It’s like buying the US dollar.. it’s just going to be worth less

Well it stopped going down last week. Let’s see if the bottom holds…

Yeah I’ve done the research on their candidate and it looks like it could be a blockbuster if ever gone to market, but then being in Australia, never taking investor phone calls, never responding to emails, enacting reverse split after reverse split, delaying and postponing trials year after year, makes it all seem unbelievable at this point.

progress is very slow in the biopharma field... Ive been waiting for First in Human trials every year that may happen in the 2nd half of "next year" for the last 6 years at least!!!

I dont want to be left out if the trials ever start. I would rather lose money, I finally made money yesterday (overall a big loss though), then miss out on announcement of First in Human trials. That would be the game changer for PPCB (imo).

Good Luck To You!

It won’t be. These cats are living in luxury making empty promises and diluting to stay alive.

I’m intrigued by this as well. But we’ve watched for many years and they’ve always failed to come through on any promises. Why would this time be any different ?

What would be remarkable is no more reverse splits from these blood suckers

Why a conference call vs. a PR? Conference calls cheaper?

This is an outrage of an Iinveswnt!
Buy anything else.. anything you will lose less money

trust me ive been involved/watching PPCB for a long time. It does have its runs and ive missed out on all of them!

This is the first time ive seen "conference call" on any PR that I can remember from PPCB. Also on the PR it stated: Management will provide insights on the remarkable results from the compassionate use study The conference call will be on March 28th, 2024 (2pm est) and I should be able to buy more shares by then.

Good Luck To You!

PR released 2-22-2024: https://www.otcmarkets.com/stock/PPCB/news/story?e&id=2774171

You are kidding, right? March 28? Sure it is 2024? It takes them as much time to organize a conterence call as it does to postpone FIH trials tome after time. Zero credibility into what they will tell, they will NEVER survive as long as the CEO rewards homself with 450000 dollars a year

News!!! Conference Call on March 28th on the compassionate use study results!!! https://www.otcmarkets.com/stock/PPCB/news/story?e&id=2774171

on a side note, Share structure updated approximately 13 million shares added to O/S from January 9th to February 9th:

Outstanding Shares: 52,144,948 02/09/2024
Restricted Shares: 727,859 02/09/2024
Unrestricted Shares: 51,417,089 02/09/2024

Buying today, hopefully I can finally catch a run with PPCB!!!!!!

still controlled by the TROLLS

Please enlighten us on this reverse spitting POS...seems like just another reverse splitting POS that can't get off the dime and deliver anything of value...meanwhile cancer keeps winning. I'm down so much it's embarrassing and I've been here for 2 years, so don't resort to "jumping in and out of stocks". This thing will RS again as soon as they get back to the trips

Small cap discussion boards are really a wasteland. If you are angry because you’re not rich, if you hate the company and come up with perpetual reasons to post hateful and erroneous comments, if you’re not willing to invest and let it ride; if you’re just in and out of stocks at random on low information, . . . if you just cook up conspiratorial bullshit about how you’re being ripped off, then why are you even here? Go invest in Apple or Tesla and just sleep soundly.

*

Foundational Patent means an Excluded Intellectual Property that is a patent that has been adopted or will be adopted into a technical standard by an international or governmental authority or association.

Y’all need to educate yourselves — ‘foundation patent.’

Exactly. I was lucky here and took a small loss.